WOODCLIFF LAKE, N.J., Sept. 8, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has resumed shipping dexmedetomidine hydrochloride (HCl) injection, EQ 100 mcg base/mL, ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Dexmedetomidine Injection, USP in ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved two sizes of dexmedetomidine hydrochloride injection for sedation purposes in ICU patients ...

MINNETONKA, Minn., July 25, 2024--(BUSINESS WIRE)--A.forall’s U.S. subsidiary Milla Pharmaceuticals Inc. announced the launch of the group’s generic version of Precedex®, Dexmedetomidine Hydrochloride ...

Credit: Hikma Pharmaceuticals. At this time, Hikma has received 1 report of an adverse event related to this recall. Hikma Pharmaceuticals is recalling 1 lot of Acetaminophen Injection, 1000mg/100mL, ...

Fresenius Kabi announced the launch of Dexmedetomidine Hydrochloride Injection, the generic version of Hospira‘s Precedex. Precedex is a selective alpha-2 adrenergic agonist. Approved by the FDA in ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a medication for ...

To earn CME related to this news article, click here. January 2, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions for clofarabine injection, dexmedetomidine HCl ...

Drug major Aurobindo Pharma On Wednesday said it has received final approval from the US health regulator for generic of Precedex injection, used for sedation of patients. The company has received ...

To investigate the effect of systemic administration dexmedetomidine, a selective alpha 2 adrenergic receptor (α 2 AR) agonist, on thermal hyperalgesia and spinal glial activation evoked by ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...